Product Description: PM-8002 is a bispecific antibody that targets both PD-L1 and VEGF-A. PM-8002 can be used for the study of solid tumors[1].
Applications: Cancer-Kinase/protease
Formula: N/A
References: [1]Lingying Wu, et al. Efficacy and safety of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with solid tumors: Clinical data from advanced cervical cancer and platinum-resistant recurrent ovarian cancer cohorts. Journal of Clinical Oncology. Volume 42, Number 16_suppl.
Molecular Weight: N/A
Compound Purity: 99.0
Research Area: Cancer
Target: PD-1/PD-L1;VEGFR